[1]简鹿豹 黄珊珊 王芙蓉 朱遂强.伴卵圆孔未闭的隐源性脑卒中的临床表现及影像学特征[J].卒中与神经疾病杂志,2020,27(02):156-160.[doi:10.3969/j.issn.1007-0478.2020.02.003]
 Jian Lubao*,Huang Shanshan,Wang Furong,et al.Clinical and imaging findings in cryptogenic stroke with patent foramen ovale[J].Stroke and Nervous Diseases,2020,27(02):156-160.[doi:10.3969/j.issn.1007-0478.2020.02.003]
点击复制

伴卵圆孔未闭的隐源性脑卒中的临床表现及影像学特征()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第27卷
期数:
2020年02期
页码:
156-160
栏目:
论 著
出版日期:
2020-03-15

文章信息/Info

Title:
Clinical and imaging findings in cryptogenic stroke with patent foramen ovale
文章编号:
1007-0478(2020)02-0156-05
作者:
简鹿豹 黄珊珊 王芙蓉 朱遂强
430050 泰康同济(武汉)医院神经内科(简鹿豹); 华中科技大学同济医学院附属同济医院神经内科[黄珊珊(通信作者)王芙蓉 朱遂强]
Author(s):
Jian Lubao* Huang Shanshan Wang Furong et al.
*Department of Neurology, Taikang Tongji(Wuhan)Hospital, Wuhan 430050
关键词:
隐源性脑卒中 卵圆孔未闭 主动脉弓斑块 弥散加权成像
Keywords:
Cryptogenic stroke Patent foramen ovale Aaortic arch atheroma DWI
分类号:
R743
DOI:
10.3969/j.issn.1007-0478.2020.02.003
文献标志码:
A
摘要:
目的 探讨伴卵圆孔未闭(Patent foramen oval,PFO)的隐源性脑卒中(Cryptogenic stroke, CS)的临床表现及影像学特征。方法 收集2014年11月-2019年6月在华中科技大学同济医院神经内科住院确诊为PFO的患者,筛选出122例存在隐源性脑卒中患者,根据头颈血管影像学检查表现将其分为主动脉弓斑块(Aortic arch atheroma, AAA)合并PFO组、轻度动脉硬化(Mild atherosclerosis, MSA)合并PFO组及单纯PFO组,比较3组的一般临床资料及影像学特点。结果 与AAA合并PFO组及MSA合并PFO比较,单纯PFO组患者年龄更小,吸烟史、高血压病史及既往脑卒中病史比例更低,反常性风险栓塞评分量表(Risk of paradoxical embolism, RoPE)数值更高(P<0.05)。影像学上AAA合并PFO组患者与MAS合并PFO组及单纯PFO组比较,其梗死灶数量更多,小病灶及累及两根以上血管和同时累及前后循环的比例更高,而MAS合并PFO组及单纯PFO组中梗死灶数量更少,大病灶及累及单根血管的比例更高(P<0.05); 单纯PFO组病灶分布于后循环的比例高于AAA合并PFO组(χ2=4.854,P=0.028); MAS合并PFO组及单纯PFO组中梗死灶数量、大小、累及的血管情况无明显差异(P>0.05)。结论 PFO引起的反常栓塞及主动脉斑块脱落栓塞可能是引起CS的重要病因,CS患者的梗死灶影像学特点能作为寻找隐源性脑卒中发病机制的线索
Abstract:
ObjectiveTo investigate the clinical and imaging features of cryptogenic stroke(CS)with patent foramen ovale(PFO).Methods Clinical data of 122 cases with patent foramen ovale and cryptogenic stroke were recruited at Department of Neurology, Tongji Hospital Affiliated to Huazhong University of Science and Technology from November 2014 to June 2019. Patients were categorized into 3 groups according to extensive cerebrovascular imaging: aortic arch atheroma(AAA)with PFO group(n=26), mild atherosclerosis(MSA)with PFO group(n=34), and PFO only group(n=62). The general information and imaging characteristics were compared among three groups.Results Clinical and radiological features differed among three groups. The PFO only group had heathier vascular risk factor profile(age, smoking history, hypertension and history of stroke), and showed higher Risk of Paradoxical Embolism scores compared with other groups(P<0.05). The AAA plus PFO group intended to cause more but smaller lesions which scattered in multiple vascular territories. The PFO only group and MSA plus PFO group intended to cause larger lesions which affected single vascular territories(P<0.05). Further, the PFO only group showed posterior circulation involvement compared with AAA group(P<0.05). There was no significant difference in number, size, and involvement of infarcts between the MAS group and PFO group.Conclusion PFO mediated peradoxical embolism and artery plaque embolism were main etiologies of CS. The imaging features of infarcts in CS patients could be used as a clue of the pathogenesis of embolism

参考文献/References:

[1] Amarenco P,Bogousslavsky J,Caplan LR,et al.Classification of strokesubtypes[J].Cerebrovasc Dis,2009,27(5):493-501.
[2] Hara H,Virmani R,Ladich E,et al.Patent foramen ovale: current pathology, pathophysiology, and clinical status[J].J Am Coll Cardiol,2005,46(9):1768-1776.
[3] Li LX,Yiin GS,Geraghty OC,et al.Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study[J].Lancet Neurol,2015,14(9):903-913.
[4] Molina CA,Santamarina E,Alvarez-Sabín J.Cryptogenic stroke, aortic arch atheroma and patent foramen ovale[J].Cerebrovasc Dis,2007,24(Suppl 1):84-88.
[5] Handke M,Harloff A,Olschewski M,et al.Patent foramen ovale and cryptogenic stroke in older patients[J].N Engl J Med,2007,357(22):2262-2268.
[6] Stortecky S,Da Costa BR,Mattle HP,et al.Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis[J].Eur Heart J,2015,36(2):120-128.
[7] Osgood M,Budman E,Carandang R,et al.Prevalence of pelvic veinpathology in patients with cryptogenic stroke and patent foramen ovaleundergoing MRV pelvi[J].Cerebrovasc Dis,2015,39(3):216-223.
[8] Tobis JM.Patent foramen ovale:Whatcardiologists and neurologistsneed to know[J].Catheter Cardiovasc Interv,2019,93(6):1085-1086.
[9] Kent DM,Ruthazer R,Weimar C,et al.An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke[J].Neurology,2013,81(7):619-625.
[10] Ryoo S,Chung JW,Lee MJ,et al.An approach to working up cases of embolic stroke ofUndetermined source[J].J Am Heart Assoc,2016,5(3):e002975.
[11] Homma S,Sacco RL,Di Tullio MR,et al.Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study[J].Circulation,2002,105(22):2625-2631.
[12] 周一方,段淑荣.卵圆孔未闭相关临床疾病的临床特点及研究进展[J].中国临床神经科学,2019,27(1):65-71.
[13] Hayashida K,Fukuchi K,Inubushi M,et al.Embolic distribution through patent foramen ovale demonstrated by(99 m)TcMAA brain SPECT after valsalva radionuclide venography[J].J Nucl Med,2001,42(6):859-863.
[14] Jeffrey L,Heinrich P,David T.Patent foramen ovale closure versus medical therapy for ctyptogenic ischemic stroke:a topic review[J].Stroke,2018,49(6):1541-1548.

备注/Memo

备注/Memo:
基金项目:2019中央高校基本科研业务费专项资金资助(2019kfyXKJC075)(2019-07-10收稿)
更新日期/Last Update: 2020-03-15